How Long Does Chin Filler Last? The Counting Method Decides

Chin filler lasts about one year for most people, and every product carrying an FDA chin indication is hyaluronic acid. In the Juvéderm Voluma XC chin study, results lasted up to one year in 58% of subjects at a median volume of 2.4 mL. In the Restylane Defyne chin study, 74% still showed at least a one-grade improvement 48 weeks after their last injection. Restylane Lyft, approved for the chin in November 2025, reported a sustained effect at month 12 for 95.5% of investigators and 89.0% of patients. Those figures describe similar results counted three different ways, which is why published estimates for chin filler run from six months to two years.

Same patients, same day, two answers: 56% and 92%

The proof sits inside a single FDA document. Allergan's patient labeling for Juvéderm Voluma XC chin augmentation reports two results from the same 182-subject study, at the same six-month visit, on the same five-point Allergan Chin Retrusion Scale. Judged from 2D photographs, 56% of subjects had at least a one-point improvement. Judged by the same doctors looking at the same patients in person, 92% did.

Nothing about the filler changed between those numbers. The camera did. A flat photograph flattens projection, and projection is the entire point of a chin.

I spent years as a radiology scheduling clerk, where you learn early that ordering a test, performing it, reading it, and treating from it are four separate jobs. Until early 2023 I told readers to ask their injector how long the result would last. I stopped. The 56/92 split is why. The usable question is: measured how, by whom, and at which visit?

The strongest objection is fair, and I grant most of it. You do not live inside a blinded photo review. You see your chin in a mirror, in profile, which is far closer to the 92% live assessment. What the 2D score buys is resistance to inflation, graded blind by someone with nothing riding on it. Only one of those numbers is hard to talk yourself into.

What the three chin-approved products actually measured

| Product | FDA chin indication | Longest chin follow-up | Headline duration figure | How it was counted | |---|---|---|---|---| | Juvéderm Voluma XC | June 2020 | 12 months | Up to 1 year in 58% of subjects | Blinded 2D photo, Allergan Chin Retrusion Scale | | Restylane Defyne | February 2021 | 48 weeks | 74% responder rate at week 48 | Blinded evaluator, Galderma Chin Retrusion Scale | | Restylane Lyft | November 2025 | 12 months | Sustained effect for 95.5% of investigators, 89.0% of patients | Unblinded investigator and patient report |

Read the right-hand column before the fourth. Lyft's 95.5% and Voluma's 58% are not the same measurement and cannot be ranked against each other. Notice also what the third column lacks: no chin study has run past twelve months. So when a clinic page says Voluma lasts 18 to 24 months in the chin, that figure came from the midface, where Voluma has been approved since 2013 and carries two-year data.

I repeated that borrowed number myself, in print. The correction cost me a retraction line and cost a reader more: he had budgeted one syringe a year on my 18-to-24-month claim, then was quoted a first treatment near 2.5 mL plus a likely touch-up. He was angry less about the money than about having planned around a figure whose anatomy I never checked.

Hyaluronic acid versus the longer-lasting classes

Longer-lasting products are not hyaluronic acid, and none carries an FDA chin indication:

• Radiesse(+), calcium hydroxylapatite. The first filler approved for jawline contour, which is adjacent to the chin but is not the chin. Correction generally lasts around a year.
• Sculptra, poly-L-lactic acid, approved in July 2009 for nasolabial folds. Its labeling describes up to 25 months in some patients, from a 233-subject randomized trial with a 106-subject extension. In nasolabial folds.
• Bellafill, PMMA microspheres in bovine collagen, approved in 2006 for nasolabial folds. Its five-year number comes from a 1,008-subject open-label study whose primary endpoint was granuloma incidence, not duration; 87% were retained at five years and 83% reported satisfaction.

Using any of these in the chin is off-label, which is legal and common, but it means your duration figure was measured elsewhere on the face, under different load. A chin gets chewed with.

The reversibility gap matters more. Hyaluronidase breaks hyaluronic acid down within hours, which is why the Restylane Defyne directions tell the injector to stop, massage the area, and follow American Society for Dermatologic Surgery guidance if skin blanches during injection. The other three classes have no equivalent rescue, and PMMA beads are non-absorbable by design. A result you dislike in an HA filler is a phone call; in a permanent material it is a surgical problem.

Volume, touch-ups, and what a year actually costs

The chin trials tell you how much product a satisfactory result took.

• Voluma XC: 0.7 to 4.0 mL, median 2.4 mL. Sixty percent of subjects needed a touch-up one month after the first treatment.
• Restylane Defyne: about 2.6 mL initially per its directions for use, with a typical 1.4 mL touch-up. Seventy-eight of 107 treated subjects (73%) took that touch-up at week 4. Maximum studied is 4 mL, split 2 mL in the chin and 2 mL below.

Then look at what those patients chose next. Offered another round at week 48, 58 of Defyne's 107 treated subjects accepted. That is the closest thing to a real-world answer for how often chin filler needs redoing.

The American Society of Plastic Surgeons puts the average hyaluronic acid filler at $715 per syringe and non-HA fillers at $901, physician fee only. At a median 2.4 mL with a 60% touch-up rate, a first chin treatment is a multi-syringe purchase, with roughly annual maintenance after. Price the decade, not the appointment.

What actually happens afterward, and how often

Voluma's chin study collected 30-day symptom diaries from 181 subjects. Some reaction was near universal: any side effect 92%, tenderness 82%, firmness 75%, swelling 69%, pain 63%, lumps or bumps 60%, bruising 59%, redness 49%, itching 28%, discoloration 15%.

Most were mild and cleared within a week; everything resolved within four. Even so, 35% of subjects had something lasting 15 to 30 days and 12% had an event rated severe. Restylane Defyne's diaries found lumps and bumps most stubborn, still present past 14 days in 30% of subjects.

One Voluma subject had three episodes of injection-site swelling beginning 173, 248, and 252 days after treatment, each clearing within three days on medication. Across that study 11 subjects had 14 serious adverse events; two were treatment-related, both in one person: an injection site inflammation lasting 153 days and a cellulitis lasting 36.

The symptoms that mean call now, not tomorrow

Unintentional injection into a blood vessel is the complication that changes the arithmetic. A 2025 systematic review and meta-analysis in Cureus put filler-induced vascular occlusion at roughly 0.01% to 0.05% per treatment, about 1 in 2,000 to 1 in 10,000. Inadvertent intravascular injection is estimated near 3 per 1,000 with calcium hydroxylapatite and 3 to 9 per 10,000 with HA. Small, not zero, and the consequences listed in FDA labeling include blindness, stroke, and permanent scarring.

The Juvéderm patient labeling names four things warranting an immediate call:

1. Changes in your vision.
2. Signs of a stroke: sudden difficulty speaking, numbness or weakness in the face, arms or legs, difficulty walking, face drooping, severe headache, dizziness, or confusion.
3. White appearance of the skin.
4. Unusual pain during or shortly after treatment.

Four more warrant a prompt call: significant pain away from the injection site, redness or swelling lasting more than a few days, and any side effect appearing weeks or months later. Pale, mottled, or dusky skin with pain out of proportion is not something to photograph and email. Call whoever injected you. If you cannot reach a human within minutes, go to an emergency department and say the words "filler" and "possible vascular occlusion."

Here is my limit. I have never had filler and I do not read images, so I could not tell you what an occluding chin feels like from the inside. What I can vouch for, after years of pulling records for people who had to prove what was done to them, is the paperwork.

The record to keep

Before you leave, get these in writing:

1. The product's full brand name and the lot or batch number from the syringe. "Filler" is not a record.
2. The volume injected, in millilitres, per site.
3. The placement. Chin trials distinguish the pogonion, the mentum, and the pre-jowl sulci.
4. The date, the injector's name and credential, and an after-hours number.
5. Standardized before-and-after photographs including a true profile view, with a copy for you.

An injector who will not name the product has answered whether to book again. The closest I get to a diagnosis is a missing record. Then set a review date: twelve months is where the published evidence stops, so twelve months is the honest point to reassess, comparing your treatment-day profile photograph against a mirror rather than memory.

The avoidable mistakes cluster in four places: shopping on price per syringe rather than on what the injector will document, accepting an unnamed product, skipping the one-month check because nothing hurts (that visit exists so the touch-up decision gets made on time), and treating the appointment as housekeeping rather than a procedure with a chart.

Deciding whether chin filler stays the right plan

More than 85% of Voluma chin subjects still felt the result suited their face at one year. Good odds on liking the outcome, and also odds on a purchase you repeat every twelve months at multi-syringe volume.

The subgroup data belongs in that decision. In Voluma's 2D photo assessment at six months, the responder rate fell below the study's own 50% threshold for subjects aged 51.5 and older (46%), for men (47%), and for subjects with darker skin (29%), though satisfaction stayed high in all three groups. If you are in one of them, ask your injector how they read that gap before you sign anything.

Frequently asked questions

Does chin filler ever fully go away?

Hyaluronic acid chin filler is temporary and the body breaks it down over time; hyaluronidase can dissolve it within hours if you want it gone sooner. FDA labeling calls the effect temporary, and both older chin trials ended around twelve months. Non-HA fillers differ sharply, since Bellafill's PMMA microspheres are non-absorbable by design.

How often does chin filler need to be redone?

Roughly once a year. Juvéderm Voluma XC's chin study found results lasting up to one year in 58% of subjects, and Restylane Defyne's showed a 74% responder rate at week 48. When Defyne's treated group was offered retreatment at week 48, 58 of 107 subjects accepted, which is slightly more than half.

Is chin filler worth getting?

That depends on your tolerance for repeat cost and repeat risk. Over 90% of Voluma chin subjects reported improved satisfaction at one year, so most people liked the result. Weigh that against annual maintenance at roughly $715 per syringe on ASPS averages, a 60% touch-up rate, and rare vascular complications.

How long does chin filler take to settle?

About one to four weeks. In Voluma's chin study, tenderness, firmness, swelling and pain generally resolved within one week, and every reported side effect cleared within four weeks. Lumps and bumps last longest: 30% of Restylane Defyne subjects still had them beyond 14 days after their initial treatment.

What side effects can occur after chin filler?

In Voluma's 30-day diaries, 92% of subjects reported some reaction, including tenderness 82%, firmness 75%, swelling 69%, pain 63%, lumps or bumps 60%, and bruising 59%. Most were mild. Thirty-five percent had something lasting 15 to 30 days and 12% had a severe event. Vision changes or pale skin need an immediate call.

How do I find out which product was used in my chin?

Ask your injector for the treatment record: brand name, lot number, volume in millilitres, and injection sites. Clinics document this because the three FDA-approved chin products carry different labels and different evidence. If your record says only "filler," request the syringe details in writing before any touch-up or maintenance appointment.